P1118: LONGER FOLLOW-UP FROM THE PIVOTAL EPCORE NHL-1 TRIAL REAFFIRMS SUBCUTANEOUS EPCORITAMAB INDUCES DEEP, DURABLE COMPLETE REMISSIONS IN PATIENTS WITH RELAPSED/REFRACTORY LARGE B-CELL LYMPHOMA

ABSTRACT:

SUBMITTER: Jurczak W 

PROVIDER: S-EPMC10431155 | biostudies-literature | 2023 Aug

REPOSITORIES: biostudies-literature